Business ❯ Healthcare ❯ Pharmaceuticals

Biotechnology

Acquisitions Cancer Treatment Pacira BioSciences Female Founders Biotech Companies Moderna Obesity Treatments Engineering Solutions Clinical Trials Cell Therapies Regeneron Pharmaceuticals Market Competition mRNA Manufacturing Biocon Ltd Biogen Alzheimer's Disease Avalo Therapeutics Neumora Therapeutics

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

No agreement has been announced, with Revolution declining to comment on the renewed takeover speculation.

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Pfizer Sues Metsera and Novo Nordisk to Block Termination of $4.9 Billion Deal

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio